Hisense Pharmaceutical (001367.SZ) plans to invest in the first phase of Hysen Pharmaceutical's new plant construction project with a total investment of not less than 2 billion yuan

Zhitong Finance App News, Hysen Pharmaceutical (001367.SZ) issued an announcement. In order to promote the company's strategic development and promote the refinement and strengthening of its main business, the company plans to sign the “Hysen Pharmaceutical New Plant Construction Project (Phase I) Investment Cooperation Agreement” with the Dongyang Economic Development Zone Management Committee to invest in the new Hysen Pharmaceutical plant construction project within the Dongyang Economic Development Zone. The total investment in the first phase of the project is not less than 2 billion yuan, and the land will be used for the construction of a new sulfur production area Raw materials such as sugar aluminum and atorvastatin calcium.

The signing of this agreement will help give full play to the resource advantages of all parties, continuously advance the strategic goals of high-quality development, enhance the core competitiveness and sustainable competitiveness of the enterprise; facilitate the company's sustainable development, achieve the company's vision of “having multiple leading pharmaceutical products, organizational ability to continuously innovate, and become a first-class enterprise with public respect, customer trust, and employee happiness”, and conforms to the company's long-term development plans and the interests of all shareholders.